Myriad Genetics Financials

Values in thousands	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Revenue	$200,400	$209,800	$205,700	$213,100
Gross Profit	137,600	146,800	143,800	151,800
EBITDA	-17,500	8,100	-9,800	-315,000
EBIT	-30,000	-4,500	-22,400	-329,100
Net Income	-34,100	-7,900	-27,400	-330,500
Net Change In Cash	200,400	209,800	205,700	213,100
Free Cash Flow	-21,100	5,900	14,900	-20,500
Cash	124,400	149,600	145,400	74,400
Basic Shares	93,700	93,300	93,100	92,500

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$824,500	$837,600	$753,200	$678,400
Gross Profit	576,600	585,400	517,000	476,400
EBITDA	-330,900	-59,500	-197,400	-84,700
EBIT	-384,600	-120,700	-259,300	-137,400
Net Income	-365,900	-127,300	-263,300	-112,000
Net Change In Cash	824,500	837,600	753,200	678,400
Free Cash Flow	-13,800	-38,400	-184,200	-151,600
Cash	149,600	102,400	132,100	56,900
Basic Shares	93,300	90,600	82,800	80,600